Latest News

Adjusting Antiseizure Medication Dosages Improves Retention of Cenobamate
Adjusting Antiseizure Medication Dosages Improves Retention of Cenobamate

December 2nd 2023

In a recent post hoc analysis of the Study C021 trial, findings support the idea that early adjustments to concomitant antiseizure medications enhance the retention of cenobamate, an FDA-approved treatment for focal seizures.

Efficacy and Safety of Antiseizure Medication Brivaracetam Maintained in Asian Patients
Efficacy and Safety of Antiseizure Medication Brivaracetam Maintained in Asian Patients

December 2nd 2023

Fetal Outcomes Largely Unaffected by Antiseizure Medication Lacosamide
Fetal Outcomes Largely Unaffected by Antiseizure Medication Lacosamide

December 1st 2023

NeurologyLive® Friday 5 — December 1, 2023
NeurologyLive® Friday 5 — December 1, 2023

December 1st 2023

Long-Term CBD Treatment in Tuberous Sclerosis Complex Effective Regardless of Age
Long-Term CBD Treatment in Tuberous Sclerosis Complex Effective Regardless of Age

December 1st 2023

AES 2023
AANEM 2023
CTAD 2023
Roundtable Discussions
NeuroVoices
Mind Moments podcast
Gold Standard Centers
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Brain Games

Conference Coverage

View All
Adjusting Antiseizure Medication Dosages Improves Retention of Cenobamate
Adjusting Antiseizure Medication Dosages Improves Retention of Cenobamate

December 2nd 2023

Empowering Patient Voice in Epilepsy Treatment and Strategies for Seizure Freedom: Patrick Kwan, MD, PhD, FRCP
Empowering Patient Voice in Epilepsy Treatment and Strategies for Seizure Freedom: Patrick Kwan, MD, PhD, FRCP

December 2nd 2023

Efficacy and Safety of Antiseizure Medication Brivaracetam Maintained in Asian Patients
Efficacy and Safety of Antiseizure Medication Brivaracetam Maintained in Asian Patients

December 2nd 2023

Fetal Outcomes Largely Unaffected by Antiseizure Medication Lacosamide
Fetal Outcomes Largely Unaffected by Antiseizure Medication Lacosamide

December 1st 2023

Video Series
Video Interviews
Podcasts

Most Recent

© 2023 MJH Life Sciences

All rights reserved.